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GRAPHICAL ABSTRACT Citrate functionalized calcium doped europium phosphate nanoparticles were crystallized by thermal decomplexing of Ca2•tEu3•{citrate{phosphate{car 
bonate solutions. The crystallization mechanism. luminescence properties and cytocompatibility of this class of nanoparticles were investigated These 
biocompatible nanoparticles appear as promising luminescent probes in the field of bioimaging. O.OlMc.-1" 0.03MCil'' 
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Bio compatible nanosystems exhibiting long lifetime ( ~millisecond) luminescence features are particu 
l arly relevant in the field of bioimaging. In this study, citrate functionalized calcium doped europium 
phosphates nanophosphors of the rhabdophane type were prepared at different synthesis times by a
bioinspired crystallization route, consisting in thermal decomplexing of ca2•tEu3• {citrate{phosphate{car
bonate solutions. The general formula of this material is Ca«Eu1 a(PO4) 1 a(HP04l,,•nH2O, with CJ. ranging 
from 0 to 0.58 and n ~ 1. A thorough characterization of the nanoparticles has been carried out by XRD 
(including data processing with Topas 6.0), HR TEM, TEM, FTIR, TG{ITTA. ICP, dynamic light scattering 
(OLS), electrophoretic mobility, and fluorescence spectroscopy. Based on these results a crystallization 
mechanism involving the filling of cationic sites with Ca21ons associated to a concomitant adjustment 
of the P04{HPO4 ratio was proposed Upon calcium doping, the aspect ratio of the nanoparticles as well 
as of the crystalline domains decreased and the relative luminescence intensity (R.LI.) could be 
modulated. Neither the pH nor the ionic strength, nor the temperature (from 25 to 37 C) affected signif
icantly the R.L.I. of particles after resuspension in water, leading to rather steady luminescence features
usable in a large domain of conditions. This new class of luminescent compounds has been proved to be
fully cytocompatible relative to GTL 16 human carcinoma cells and showed an improved cytocompatibil
ity as the Ca2+ content increased when contacted with the more sensitive m17. ASC murine mesenchymal
stem cells. These biocompatible nanoparticles thus appear as promising new tailorable tools for biomed
ical applications as luminescent nanoprobes.3+1. Introduction
Materials at the nano scale possess unique optical, magnetic,
and chemical properties which allow the creation of imaging
probes with better contrast enhancement, increased sensitivity,
improved signal to noise ratio and better spatial and temporal
information in comparison to the conventional imaging agents
[1]. Among them, luminescent nanoparticles are excellent optical
probes that can significantly extend the capabilities of well
established fluorophores such as organic dyes and genetically engi
neered fluorescent proteins [2]. Their advantages include also
excellent photostability, tunable and narrow spectra, controllable
size, resilience to environmental conditions such as pH and temper
ature, in combination with a large surface for anchoring targeting
biomolecules [2]. Their function is mainly to provide the necessary
fluorescent contrast required to visualize specific cellular compo
nents and tissues [3]. Several luminescent nanomaterials including
quantum dots [4], nanodiamonds [5], gold nanoparticles [6], nanos
tructures labeled with organic dyes [7], nanocrystalline calcium
orthophosphate apatites labeled with lanthanide ions or organic
dyes [8 11] and others, have been proposed as fluorophores for
these applications. In recent years, lanthanide orthophosphates
(LnPO4) have attracted much attention because they exhibit low
solubility in water, high thermal conductivity and high refraction
index, thus being candidates for a wide range of applications
including phosphors, catalysts, sensors, heat resistant materials
[12] and also, as optical probes for bioimaging [13,14]. As imaging
agents the favorable features of lanthanide doped nanoparticles
include large effective Stokes shift, sharp emission peaks with nar
row band width, low photobleaching, stability to photochemical
degradation, long luminescence lifetimes, low toxicity and the
absence of blinking [10 15].
Lanthanide orthophosphates LnPO4 nH2O (n = 0 2) (Ln3+ = lan
thanide ion) present five polymorphic modifications, i.e. monazite
(monoclinic), xenotime (tetragonal), rhabdophane (hexagonal),
weinschenkite (monoclinic) and orthorhombic [16]. The hexagonal
structure is usually the low temperature phase and it can trans
form into the monazite structure, while the tetragonal phase main
tains its structure after calcination at 900 C [17,18]. Different
methods to prepare LnPO4 nH2O nanocrystals with controlled mor
phologies such as nanorods, nanowires or nanocables have been
proposed. Synthetic methods are based on high or low temperature
approaches, such as hydrothermal synthesis [19 22], ultrasound
irradiation [23], precipitation in oil baths [24], sol gel combined
with electrospinning [25], surfactant assisted methods to mediate
the slow crystallization of the nanocrystals [26], or else layer by
layer deposition of precursors followed by crystallization at room
temperature [27].
Among lanthanides ions, trivalent europium, Eu3+, has been
used to crystallize luminescent compounds such as EuPO4 nH2O,
or Eu3+ doped LnPO4 of the hexagonal form with improved energy
transfer efficiency between the Ln3+and Eu3+ [14,27 29]. From
another perspective, crystallization of EuPO4 nH2O has been also
considered as a method to separate Eu3+ impurities from phospho
ric acid solutions obtained from calcium phosphate apatite rocks[30,31]. The presence of Eu impurities is assumed to result from
Eu3+ to Ca2+ substitution in the apatite structure. Ca substituted
EuPO4 nH2O crystallizes in such acid solutions due to the presence
of Ca2+ as main impurity [31].
Luminescent Ln3+ doped calcium phosphate (apatite) nanopar
ticles have been extensively studied as materials for diagnostics
and therapeutic applications [10,11,13,14] while Ca substituted
EuPO4 nH2O has never been proposed for similar topics. Compared
to the precipitation of Ln3+ doped apatite nanoparticles [32,33], a
main advantage of EuPO4 nH2O is related to its reduced polymor
phism; the hexagonal rhabdophane structure being the crystalline
phase that usually precipitates at low temperatures [28]. In con
trast, during the calcium phosphate crystallization at low tempera
ture several polymorphs, including monetite, brushite, octacalcium
phosphate and apatite can eventually appear [34,35,36], depending
on experimental conditions.
In the present work we have prepared Ca doped europium
phosphate nanocrystals of the hexagonal phase employing a bioin
spired synthetic route consisting in thermal decomplexing of Eu3+/
Ca2+/citrate/phosphate/carbonate solutions method and assessed
their luminescence and cytocompatibility properties. The pro
posed technique, which was previously used to precipitate cal
cium phosphate apatite nanoparticles doped with different
metallic ions and coated with citrate [37 39], is one pot, straight
forward, easily scalable to an industrial level, and respects the
principles of green chemistry. The presence of Ca2+ in the structure
of the nanocrystals as well as of citrate adsorbed on the surface of
the constitutive particles (a feature found in bone apatite
nanocrystals [40]) are expected to be beneficial from the point
of view of the cytocompatibility that is required for bioimaging
applications.2. Materials and methods
2.1. Reagents
Europium chloride hexahydrate (EuCl3 6H2O, ACS Reagent,
99.9% pure), calcium chloride dihydrate (CaCl2 2H2O, Bioxtra, 
99.0% pure), sodium citrate tribasic dihydrate (Na3(Cit) 2H2O
where cit = citrate = C6H5O7, ACS reagent, 99,0% pure), sodium
hydrogenphosphate (Na2HPO4, ACS reagent, 99.0% pure), sodium
carbonate monohydrate (Na2CO3 H2O, ACS reagent, 99.5% pure),
and hydrochloric acid (HCl, ACS reagent, 37 wt% in H2O) were pro
vided by Sigma Aldrich. All solutions were prepared with ultrapure
water (0.22 lS, 25 C, Milli Q, Millipore).2.2. Precipitation method
Nanoparticles were synthesized as follows: a solution of com
position (a) 0.12 M Na2HPO4, + 0.2 M Na2CO3, with pH adjusted
to 8.5 with diluted HCl, was poured on a solution of composition
(b) xCaCl2 + yEuCl3 + 0.4 M Na3(cit) (with x) being the doping Ca2+
concentration 0.01, 0.03, 0.05 and 0.06 M and y = 0.1 x M)
(1:1 v/v, 200 mL total) at 4 C. The mixed solution was introduced
in a 200 mL bottle made of Pyrex glass, sealed with a screw cap
and, without delay, immersed in a water bath at 80 C and then
moved to an oven with circulated forced air at the same tempera
ture. The experiments lasted between few minutes and few days.
Once finished, the precipitates were subjected to 6 consecutive
cycles of washing by centrifugation with ultrapure water to
remove unreacted salts. Afterwards they were freeze dried over
night at 50 C under vacuum (3 mbar).
2.3. Characterization techniques
The precipitates were characterized by X ray powder diffraction
(XRD), Fourier transform infrared (FTIR) spectroscopy, scanning and
transmission electronmicroscopy (SEM, TEM), high resolution TEM
(HR TEM), and fluorescence spectroscopy. Selected samples were
analyzed by dynamic light scattering (DLS), f potential and thermo
gravimetry/differential scanning calorimetry (TG/DTA). Ca, P and Eu
contents were quantified by inductively coupled plasma optical
emission spectrometry (ICP OES) spectrometer.
The X ray powder diffraction data were collected using a Bruker
D8 Advance Vario diffractometer with a Bragg Brentano parafocus
ing geometry and Cu Ka1 radiation (1.5406 Å). Data processing was
conducted via the software TOPAS 6.0 [41]. The contribution of the
anisotropic peak broadening due to domain size was modeled
using the ‘‘AnisoCS” TOPAS macro developed by Ectors et al.
[42,43] based on the size Voig approximation, and taking into
account the instrumental contribution from a measurement of
LaB6 standard (NIST SRM 660c). A biaxial ellipsoid model was
selected to fit the experimental data, and the anisotropic sizes
obtained are the main radii area weighted in nm.
Fourier transform infrared spectroscopy was used for comple
mentary characterization of the samples. In a first stage, spectral
acquisitions were run using a JASCO 6200 FTIR spectrometer
equipped with an attenuated total reflectance (ATR) accessory.
Subsequently, more in depth analyses were drawn from spectra
recorded in transmission mode using a Perkin Elmer Spectrum
One FTIR spectrometer using the KBr pellet method. The pellets
were prepared by mixing 1 mg of sample with 100 mg of anhy
drous KBr and then pressed with a hydraulic pump at 10 t into
7 mm diameter discs. Pure KBr pellets were used to record the
background. FTIR spectra in transmittance mode were recorded
within the wavelength range from 4000 cm 1 to 400 cm 1.
TGA DTA analyses of the samples were carried out in a simulta
neous thermal analyzer (STA 449 Jupiter Netzsch Geratebau, Selb,
Germany). About 10 mg of sample was weighted in a platinum cru
cible and heated from room temperature to 1000 C under air flow
with a heating rate of 10 C/min.
The chemical composition of the samples was determined dis
solving the samples in a diluted HNO3 solution (1 wt%) and then
analyzed by an ICP OES (Liberty 200, Varian, US) employing wave
lengths of 422.673 nm (Ca), 420.504 nm (Eu), and 213.618 nm (P).
Transmission electron microscopy (TEM) observations and
selected area electron diffraction (SAED) analysis were performed
with a TEM Libra 120 Plus instrument from Carl Zeiss microscope
operating at 80 kV. Resolution point point is 0.34 nm and magnifi
cation is 8 630,000x. Samples were dispersed in ethanol (absolute,
99.8%) using an ultrasound bath. Then a few droplets of the slurry
were deposited on conventional copper microgrids with FORMVAR
carbon film prior to observation. HR TEM analysis was performed
with a TITAN G2 60 300 FEI Instrument operating at 300 kV. The
instrument is equipped with EDX Super X detector to perform
microanalysis and STEM type HAADF.
The analysis of the particle size distribution and electrophoretic
mobility (transformed to f potential values) of suspensions was
performed in a Zetasizer Nano ZS analyzer (Malvern, UK) using disposable polystyrene cuvettes containing the particles suspended in
deionized water (0.5 mg/mL) at 25 C. Samples were immersed in
ultrasonic bath for 5 min prior to DLS analysis. For the measure
ments of the f potential versus pH the MPT 2 autotitrator (Mal
vern, UK) connected to the analyzer was employed. Diluted HCl
and NaOH solutions (0.25 and 0.1 M, respectively) were used as
titration agents. No additional electrolytes were added.
2.4. Luminescence spectroscopy
Excitation and emission spectra of the solid samples as well as
of aqueous suspensions of the nanoparticles (0.5 mg/mL) were
recorded using a Cary Eclipse Varian Fluorescence Spectropho
tometer (Varian Australia, Mulgrave, Australia) with an R928 pho
tomultiplier tube (Hamamatsu, Iwata gun, Shizuoka ken, Japan).
For solid nanoparticles k exc was 394 nm, kem 614 nm, delay time
(td) was 0.120 ms and gate time (tg) was 5 ms. Spectra were
recorded with a photomultiplier voltage of 500 V. The excitation
and emission spectra were recorded within the range 250
500 nm and 500 750 nm respectively. For nanoparticles in aque
ous suspensions, the following conditions were used: kexc
230 nm, kem 614 nm, td 0.120 ms and tg 5 ms. In this case the pho
tomultiplier voltage was 600 V and the excitation and emission
spectra were recorded within the wavelength range 200 550 nm
and 400 750 nm respectively.
2.5. Cytocompatibility tests
GTL 16 (a human gastric carcinoma cell line) and m17.ASC (a
spontaneously immortalized mouse mesenchymal stem cell clone
from subcutaneous adipose tissue) cells (12,000 and 5,000 cells/
well in 96 well plates, respectively) were incubated for 24 h and
then different concentrations of the differentially doped (x = 0.01,
0.03, 0.05, 0.06 M Ca2+) particles, ranging from 0.1 to 100 mg/ml,
were added in 100 mL of fresh medium. After 72 h incubation, cell
viability was evaluated by the 3 (4,5 Dimethylthiazol 2 yl) 2,5 di
phenyltetrazolium bromide) (MTT, Sigma) colorimetric assay.
Briefly, 20 mL of MTT solution (5 mg/ml in a PBS solution) were
added to each well. The plate was then incubated at 37 C for
3 h. After the removal of the solution, 125 mL of isopropanol,
0.2 M HCl was added to dissolve formazan crystals. 100 mL were
then removed carefully and the optical density was measured in
a multiwell reader (2030 Multilabel Reader Victor TM X4, PerkinEl
mer) at 570 nm. Viability of parallel cultures of untreated cells was
taken as 100% viability, and values obtained from cells undergoing
the different treatments were referred to this value. Experiments
were performed 4 times using 3 replicates for each sample.
Statistical Analysis. Data are expressed as mean ± standard devi
ation of at least three replicates. Statistical analyses were per
formed using a one way ANOVA with Bonferroni’s post test for
grouped analyses using GraphPad Prism version 4.03 for Windows,
GraphPad Software (GraphPad Prism, San Diego, CA). Differences at
p < 0.05 were considered to be statistically significant.
3. Results and discussion
3.1. Crystallographic, compositional, morphological and spectroscopic
characteristics
The XRD patterns of samples precipitated in the presence of
increased Ca2+ doping concentrations (x = from 0.01 to 0.06 M) at
different maturation times are reported in Fig. 1.
The patterns mainly display the distinguishing reflections of the
hexagonal phase of EuPO4 nH2O (rhabdophane), space group P3121
(PDF 20 1044) with lattice constants a = 6.910 Å, and c = 6.340 Å.
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Fig. 1. X- raydilfraction patterns of the samples precipitated using increasing Ca� doping concentrations: (a)0.01 M; (b)0.03 M; (c)0.05 M and (d)0.06 M. •EuPO4-H2O(PDF 
20-1044} # Reflection of (1 0 0) plane of octacalcium phosphate (OCP, POF 44--0778} • Reflections (1 0 1) and (11 4) of CaC03 vaterite (Y, PDF 3 3-0268). The main reflections of this phase are situated at 2014.67° (100),
20. 35 ° (1 0 1  ), 25 . 80° (1 1 0), 29.77° (2 0 0), 31. 95 ° (1 0 2),
38.44°(1 1 2) 42.61°(00 3) and 49.46° (2 1 2 ) . The diffraction peaks
at the shorter maturation times are broad and poorly defined sug 
gesting a relatively lower degree of crystallinity and nanodimen 
sions. The evolution with maturation time of the full width at
half maximum (FWHM) of the two main retlections at 29.77° and 
31.95 ° indicates an increase in size or crystallinity up to 48 h
for x = 0.010 M ea2•. 24 h for x = 0.030 M ea2•. 96 h
for x = 0.050 M ea2+and 21 days for x = 0.06 M ea2•. Only a small
decrease in size or crystallinity can be deduced after 24 h matura 
tion for x = 0.03 M ea2•. No peaks assignable to other crystalline
phase were identified when using the 0.01 M ea2• doping concen
trations even for early precipitation times (Fig. 1 a). On the con 
trary, the samples precipitated using the 0.06 M ea2• 
concentration show a different phase evolution (Fig. 1d) . At matu 
ration times of 5 min, 1 h and 24 h the main retlection at 20 = 4.74° 
assignable to (1 0 0) plane of octacalcium phosphate (OCP, PDF 44 
0778) is present. The broad width of this retlection along with the
bulging of the baseline in the 20 range from 22° to 38° suggests the
nanocrystalline character of the OCP phase. The peak at 4.74° wasnot observed in the samples matured for more than 24 h, which in
tum, shows mainly the reflections of the hexagonal phase of
EuP04 nH20. Thus the formation of OCP in early stages was only
transient until final ion reorganization of the system took place. 
For ea2• doping concentrations x = 0.03, 0.05 and 0.06 M,
traces of an additional phase start to appear at high maturation
time, which is especially visible at around 20 ~ 27.0 and 32. 8° .
These additional peaks detected for high calcium concentrations 
are attributed to the retlections (101) and (1 1 4) of CaC 03 vaterite
(PDF 33 0268 ), eventually doped with europium, which becomes
stable in the calcium rich medium. According to JC P OES data 
(see below) an amount close to 0 .4, 10 and 14 wt% respectively 
for 0.03, 0.05 and 0.06 M was evaluated for 96 h of maturation,
besides the europium phosphate phase. In contrast, no vaterite
was detected for the lowest ea2• concentration (x =0.01 M) or for
low maturation times, where the samples consist solely in single
phased Ca doped EuP04 nH20. Vaterite is a highly biocompatible
allotropie form of calcium carbonate that is used in the biomateri 
ais field, e .g .  for the setup of bone cernent formulations [44). The
eventuality of traces of this minor phase is thus not problematic
per se for biomedical applications; in any case, we show here
the possibility to avoid its presence if needed, by adequately 
tailoring the precipitation conditions such as calcium doping 
concentration. 
The micro structural study of samples matured for 96 h, analyz 
ing the full XRD pattern of the Ca doped EuPO4 nH2O with TOPAS 
6.0 software (Fig. 2 and Table 1), reveals a trend from elongated 
to more isometric shapes of the single crystal domains when 
increasing the ea2+ doping concentration. The coherent length (L) 
of the domains (Table 1 and insets in Fig. 3) evolves from 
13.3 ± 0.1 nm for the Jess Ca doped sample to 6.9 ± 0.2 nm for the 
highest ea2• concentrations. Similarly, the aspect ratio switches 
from 3.6 to 1.1. The sample obtained for x = 0.05 M ea2• displayed 
a coherent length and width almost doubled of that obtained 
for x = 0.03 M ea2• in spite of similar aspect ratios. Note that in 
ail panels of Fig. 2,,: is slightly higher than 1.6, which indicates that 
the population of single crystal domains is polydisperse. 
TEM observations (Fig. 3a d) allowed visualizing the morphol 
ogy and average dimensions of the nanoparticles, which were 
found about 3 times larger than the sizes determined by Rietveld 
refinement. It is important to remark that TEM and XRD allow eval 
uating two different features of the material (observed particles 
size vs coherent size of crystal domains) therefore only the general 
trend of data can be compared. a 
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Fig. 2. Microstructural evolution of the single crystal domains of Ca-<loped EuP04-nH2O 
(a) 0.01 M; (b) 0.03 M; (c) 0.05 M and (d) 0.06 M. The two XRD vaterite re0ections a
polydispersity factor (1 �, � 2), being 2 the theoretical limit for the Gaussian part of thThe average dimensions of the particles determined by TEM 
(Table 1) typically varied from 40 ± 7 nm in length with the aspect 
ratio (length/width) of 5 for the Jess Ca doped sample (1.3 wt% Ca) 
to 19 ± 7 nm in length with the aspect ratio of 2.54 for the sample 
with the highest Ca content (14 .2 wt% Ca). It is thus observed that 
increasing the ca2+ content the nanoparticles are in general more 
isometric with ill defined shape. In the case of x = 0.05 M ea2• 
we found a mixture of elongated and ill defined isometric 
nanoparticles, therefore this doping point can represent the transi 
tion between these two morphologies. 
Fig. 3e and f show the STEM images in bright field (BF) and high 
angle annular dark field (HAADF) of the Jess Ca doped sample. The 
indexed SAED pattern (Inset of Fig. 3f) of this sample shows the 
crystallographic planes of the hexagonal rhabdophane phase, i.e. 
(1 on (110), (200), (10 2), (112), (2 12), (300) and (32 2). 
HRTEM images of the same sample (Fig. 3g and h) reveal the lat 
tice fringes of the nanoparticles, mostly structured as single crystal 
domains, whose d spacings correspond to planes (2 0 0) and (1 0 2) 
as also revealed in the FFT images (insets of Fig. 3g and h). The ele 
mental mappings of the Jess Ca doped nanoparticles (Fig. 3i 1) 
show a homogeneous distribution of Ca, Eu, 0 and P. 
TGA DTA analyses (see SI, Fig. S1) revealed a rather comparable 
behavior for ail samples, and the data are very close to those b 
d 
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nanoparticles of samples precipitated at 96 h using the Ca� doping concentrations: 
re excluded. Rwp and R,.p are agreement factors in% for the refinement , is a 
e size Voig approximation used. 
reported for similar materials [45 48). The main weight tosses 
occurred in the range T,oom 700 °C corresponding to the loss of 
adsorbed and structural water, white the weight loss between 
700 and 1000 °C, that is more evident in the samples prepared Table 1 
Quantitative compositional, elemental chemical analysis and average size (length 
concentration x from 0 to 0.06 M, at 96 h. 
ca2• mol/L Value' of Analyzed Elements (wt%) 
a(±0.05) Eu• ca• P' H:i() Adsolbed
0 0 53.0 ±3.0 0 10.6 ±0.6 6.0± 0.6 
0.01 0.09 51.0±2.0 1.3 ± 0.1 11.9±0.4 2.1 ±0.2 
0.03 0.30 43.7 ±0.3 4.9 ± 0.1 12.6 ±0.1 3.7 ±0.4 
0.05 0.49 31.5±0.1 11.6±0.1 12.6 ±0.1 4.3± 0.4 
0.06 0.58 262±0.3 142 ±0.1 12.6 ±02 5.6± 0.6 
Rietveld Refinement< (TOPAS 6.0) 
Length {L, nm) Width (W, nm) R1 (L/W) as
0.01 13.3 ± 0.1 3.7 ± 0.3 3.6 
0.03 62 ± 02 3.7 ±0.3 1.7 
0.05 12.8 ± 0.1 6.7 ± 02 1.9 
0.06 6.9 ± 02 5.7 ±02 1.1 
• Measured by ICP-OES; 
• measured byTGA-DTA 
c aver<lge dimensions (c oherent length and width) of the single crystal domains deter
d aver<lge dimensions of the nanoparticles determined by TEM; 
• without mentioning here H2O, citrate and carbonate ions; 
r counting H:i(), citrate and carbonate (vaterite) ions; 
g value of a in the chemical formula Eu1 aCaa(PO4), a(HPO4)a•nH:i() 
Fig. 3. ( a-d) TEM micrographs of Ca-<loped cit-EuP04-�O nanoparticles prepared with di
0.06 M. lnsets show the indexed SAED patterns of the nanoparticles.{e, 1) BF HAADF-STEM
Ca2* lnset in (1) shows the indexed SAED pattern {g,h)HR-TEM images showing some latt
of 0.01 M. lnsets show the corresponding FFT im<lges displaying the {1 0 0), (2 0 0) and {1using the higher ea2• doping concentrations, is associated to the
loss of C02 from the carbonate decomposition ofvaterite. ln details, 
the first weight loss of about 2 6 wt%, attributed to the residual 
adsorbed water on the powder surface due to the storage and width) of Ca-ooped cit-EuP04-nH:i() samples prepared with Ca2* doping 
Calculated oxide components (wt.%)' Totalr (wt.%) 
b 
�Q Structural
b Eu:i()3 CaO P2Os 
5.8 ± 0.7 61.4 ± 12 0 24.3 ± 1.0 100.2± 3.1 
5.4 ± 0.5 61.7±12 1.9 ± 0.1 28.5 ± 1.0 100.0± 3.1 
62±0.6 52.4 ±0.3 7.1 ± 0.1 29.9 ±02 100.3± 1.7 
6.6 ± 0.7 37.5 ±0.1 16.7 ±0.1 29.6 ±02 100.5± 1.7 
6.4±0.6 30.8± 0.3 202±02 29.3 ±0.4 100.1 ± 2.3 
TEMd 
pect ratio L, nm W, nm R2 (L/W) aspect ratio 
39.5 ± 7.1 7.9 ± 1.6 5.0 
19.7 ± 32 6.9 ± 2.6 2.8 
41.1 ± 7.1 16.4 ± 5.7 2.5 
19.3 ± 6.9 7.6 ± 2.0 2.5 
mined by Rietveld refinement of the full diffraction pattern with TOPAS 6.0; 
lferent Ca2+ doping concentrations at 96 h: (a) 0.01 M; (b) 0.03 M; ( c) 0.05 M and ( d) 
 micr ographs of the sample prepared with the Ca2* doping concentration of0.01 M 
ice fringes and d-spacing of the sample prepared with the Ca2* doping concentration 
 0 2) planes. (i-1) EDX Element mapping analysis of the sample displayed in panel f. 
conditions in air, was found up to 120 °C with a broad endotherrnic 
peak in the range 50 100 °C in the DTA curve. The second weight 
Joss began at about 120 °C and finished at about 700 °C. lt corre 
sponds to the dehydration (release of structural water) of the 
hexagonal phase. This step proceeded in two sequences. An impor 
tant weight Joss was registered up to about 350 °C and then it 
decreased slowly to 700 °C. This event was accompanied by a 
broad endotherrnic effect. The exotherrnic peak in the range 750 
950 °c represents the phase transformation of the lanthanide 
orthophosphate from hexagonal to monoclinic [28). 
Table 1 gathers the compositional information relative to the 
samples. ln particular two interesting findings can be pointed 
out: (i) while the P wt% remained almost constant in all samples, 
the Ca wt% increased and the content of Eu accordingly decreased; 
(ii) the weight Joss corresponding to the structural H2O accounts
for about 5 7 wt%, which is equivalent to a hydration content n
of about 1 mol of H2O (Table 1 ). 
On the basis of these analyses, it is interesting to examine in 
further details the chemical composition of the samples. Phosphate 
groups are large ionic entities ensuring, as in many phosphate 
compounds such as apatites, the stability of the crystallographic 
structure. Therefore, the existence of phosphate vacanàes is very 
improbable as this would most likely destabilize the whole struc 
ture. Also, the carbonation of LnPO4 phases has not been reported 
to our knowledge. Yet, since the crystal electroneutrality has to be a 
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Fig. 4. {a-d) FTIR spectra of samples synthesized at Ca2• doping concenpreserved upon Ca for Eu substitution, the replacement of triva 
lent Eu3• cations by divalent ea2• should be undergone with simul 
taneous protonation of an equivalent number of P� ions into 
HP� . This presence of HP� ions in calcium doped europium 
phosphate has already been considered in the literature.31 This 
leads for the samples generated in the present study, and excluding 
citrate for simpliàty of writing, to the general formula Eu1-
aCaa(PO4)t.a(HPO4)a nH2O with 0 � a � 1. From ICP data, the esti 
mated value of "a" ranges between 0 and 0.58 for x varying from 0 
to 0.06 M ea2•. For samples corresponding to x = 0.03, 0.05 and 
0.06 M, an additional amount of vaterite is then also present, 
reaching 0.01, 022 and 0.30 mol per mole of europium phosphate, 
res pectively. 
For complementary characterization of the samples, FTIR spec 
troscopy was also applied, and Fig. 4a d show the spectra of the 
samples obtained upon increasing ea2• doping concentration. They 
display similar spectroscopie features and show the expected glo 
bal shape of a rhabdophane phase [45,48) with a broad band in the 
range 1000 1100 cm 1, related to the asymmetric stretching mode
of P� groups (U3 PO4), and two intense bands at ~620 and 
535 cm 1 due to the bending mode of PO¾ ions (u4 PO4). The broad
band observed between 36 00 cm 1 and 2600 cm 1 corresponds to
the 0-H stretching from the associated water. Severa) spectral 
contributions also point to the presenœ of citrate molecular ions, 
with contributions at 2926 and 2856 cm 1 assignable to theb 
5 min 
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d 
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3000 2000 
Wavenumber (cm-1)
3000 2000 
Wavenumber (cm-1)
0.03 M Ca2+
1000 
0.06 M Ca2+ 
1000 
trations 0.01, 0.03, 0.05 and 0.06 Mat dilferent maturation times. 
stretching vibration of Œl2 groups [49), a smalt band detected here 
around 867 cm 1 which can be related to the bending mode of 
COQ- groups [50), and broad signais at about 1590 cm 1 and 
1402 cm 1 assignable to the antisymmetric and symmetric 
stretching of carboxylate ( -COQ ) groups of the adsorbed citrate, 
respectively [51 ). 
Traces of CaCO3 vaterite have been revealed previously from 
XRD analysis for x = 0.003, 0.05 and 0.06 M ea2•. at least at high 
maturation times. The presence of this secondary phase explains 
the modifications observed in the 830 890 cm 1 and 1250 
1550 cm 1 ranges ( e.g. for 96 h of maturation, see ES, Fig.S2). In 
these regions are located not only COQ vibrations from citrates, 
as mentioned above, but also of carbonate ions when present 
(respectively their v2CO3 and v3CO3 vibration modes). The contri 
butions initially present at 867 and 1402 cm 1 for low Ca doping 
and single phased systems are shifted to around 872 and 
1412 cm 1 in the case of samples x = 0.05 and 0.06 M ea2•. which 
can be explained by the co presence of traces of vaterite [52) 
known to lead to vibration bands at 870 and 1420 cm 1. It may 
also be noted that the presence of HPOl ions, which is expected 
to give a band around 870 880 cm 1, cannot be detected in this 
work due to the presence of other vibration due to citrates and car 
bonates in the same domain. 
3.2. Crystal size distribution and electrokinetic properties (C potential) 
byDIS 
The analysis of crystal size distribution (CSD) and surface Ç 
potential is fundamental to evaluate the potential applications of 
nanoparticles as drug delivery vehicles or as luminescent probes 
in medical imaging [53). In the present study it was decided to plot 
the volume based frequency distribution of the different ea2• 
doped cit EuPO4 H2O samples because they clearly show the per 
centiles of the distribution D10 and D5() (Fig. Sa and S3 of SI). These 
percentiles represent the percentage of cumulative volume under 
size distribution ( percentage of the population smaller than the 
size indicated). Thus, D10, which is the percentile more close to 
the size of the fine individual particles, is always within the 
nanometer size range white Dso, which represent the median 
diameter of the CSD, is here partially influenced by particle aggre 
gation. � (not shown) is fully influenced by the aggregation of 
nanocrystals. 
It is worth mentioning that median diameters for samples pre 
pared with x = 0.01 (D50 = 44 nm), 0.05 (D50 = 164 nm) and 0.06 M 100 
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Fig. 5. (a) Cumulative volume oversize distribution of the Ca-doped cit-EuP04-nHzO nanoc
EuP04-nHzO nanocrystals prepared at 96 h. ea2• (D50 = 80 nm) are quite close to those of D10 (28, 38 and 
52 nm, respectively) and that D10 defines well the size of individual 
nanoparticles, particularly for x = 0.01 and 0.05 M ea2• (L mea 
sured byTEM of 39.5 and 41.1 nm, respectively). This fact indicates 
that aggregation is very low below the median diameter of the CSD 
and negligible below D10. Considering that C potential of the sus 
pension affects the aggregation state of the nanoparticles, i.e. the 
lower the absolute value of the C potential the greater the trend 
to aggregation, it is deduced that the interactions among nanopar 
ticles are very weak. The aggregates are broken only after 5 min 
sonication, in spite of the low values of the Ç potential at any of 
the pHs analyzed (Fig. Sb). Only for x = 0.03 M ea2•. with D50 
955 nm and D10 68 nm the aggregation process is more important. 
For this sample the Ç potential within the pH range from 4 to 10 is 
doser to zero. We have not found a general trend relating the evo 
lution of the CSD with the ea2+ doping concentration nor with the 
maturation time of the preàpitates (see Fig. S3a d). 
The above findings confirm that we succeeded in preparing Ca 
doped citEuPO4 nH2O nanoparticles of the hexagonal rhabdophane 
phase with a tailored ea2• content and adsorbed citrate on their 
surface, a chemical feature which is also exhibited by bone apatites 
[40). The aspect ratio of both the single crystal domains and the 
observed nanoparticles decreased as the ea2• content increases. 
To explain these results an important issue is the analysis of the 
growth behavior of the lanthanide orthophosphates. In general, 
those crystals with hexagonal mabdophane type structure grow 
along the [ 0 0 1) direction resulting in the formation of nanowires 
or nanorods. The growth morphology, however, results from the 
interplay between the growth rates of the outermost crystallo 
graphie planes of the nanocrystals and the inhibiting/promoting 
effect of the additives or templates in solution. Therefore, the first 
key influence to consider when analyzing the morphology is that of 
the crystalline structure. 
The overall rhabdophane structure has been described as col 
umns built up of alternate lanthanide ions, with eight fold coordi 
nation, and tetrahedral orthophosphate ions [12). These columns, 
or periodic bond chains, are extended along the c axis, each one 
linked to four neighboring columns, consequently forming open 
channels that run through the structure along the c axis. These 
large channels incorporate structural H2O molecules, between 0.5 
and 2 molecules per formula unit, which might stabilize the hexag 
onal crystal structure [28,54). From a thermodynamic point of view 
the activation energy for crystal growth along the c axis must be 
lower than that in perpendicular directions along the a or b • 0.06 M Ca2' 96 h
4 • 0.05 M Ca2' 96 h
• 0.03 M Ca'' 96 h
• 0.01 M Ca2'96 h
2 0.0 M Ca2' 96 h 
0
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600 b axis, thus indicating that [0 0 1] will be the preferential growth 
direction. 
A second key influential factor is linked to the presence of addi 
tives in the solution Citrate ions are expected to play here two dif 
ferent rotes during the precipitation of the nanoparticles: (i) it is a 
medium strength M2•!3• ligand that enables the preparation of
metastable ea2•/Eu3• /àtrate/phosphate/carbonate solutions at
slightly basic pH; these complexes can be easily destabilized by 
increasing the temperature, thus releasing the M2•!3• ions and
leading to the precipitation of the ea2• doped nanoparticles. (ii) 
After the nucleation event the embryonic nanoparticles, initially 
amorphous, quickly transformed to crystalline nanophases, which 
may also be influenced by citrate ions. Taking into account their 
3 peripheral carboxylic acid heads, free àtrate ions may selectively 
adsorb on specific outermost planes of forming nanophases, slow 
ing down in particular the growth along the [ 0 0 1] direction, thus 
leading to the formation of nanorods instead of long nanowires 
with high aspect ratios. Most probably these planes are (h 0 0} 
and {h 0 I} since faces (1 0 0) and (1 0 1) are displayed on the 
growth morphology (Fig. 3g). 
The trend to lower aspect ratios and formation of ill defined 
morphologies in the nanoparticles described in this work is thus 
attributed not only to the effect of incorporating ea2• in their crys 
tal structure, which affects the type of periodic bond chains, but 
also to the above effect of citrate. The formation of nanoparticles 
with lower aspect ratios was also found in other doped nanoparti 
des in carboxylate free solutions, i.e. doped apatite [55], thus prob 
ing that metal ions also con tri bute to the inhibiting effect of crystal 
growth along the [0 0 1] direction. 
lt is also worth noting the behavior of the nanoparticles in 
water suspensions. We have found that in some of the samples 
the trend to aggregate is low below the median diameter of the 
CSD and negligible below D10. 
ln ait samples the s potential values are slightly negative at pH 
7 and 5 (Fig. Sb). These pH values are close to the physiological pH 
in blood circulation and to the more acidic pH in the endosome 
lysosome intracellular compartment, respectively. These low neg 
ative values of the C potential can be explained on the basis of 
the balance between the interactions of the negatively charged free 
carboxylate groups (-COQ ) of the adsorbed citrate molecules 
with the aqueous medium and those with the solid phase. The for 
mer should be weaker than the latter, i.e. electrostatic interaction 
of the -COQ groups with the partially charged surface 
groups >Eu&+> ea&+, > POl of the outermost layer of the nanopar 
ticle surfaces, thus exposing less ionic charge toward the medium. 
This detail indicates that interactions between nanocrystals within 
the nanosized range are very weak, so that dispersion is easily 
achieved by simple agitation, sonication, or else, by a subsequent 
functionalization of the nanoparticles with a biocompatible ligand. 500 
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Fig. 6. Excitation (dashed lines) and emission (solid lines) uncorrected spectra of 
Ca-<loped cit-EuP04-nH:i() prepared with x • 0.03 M Ca2• at maturation times of 
5 min, 1 h, 2 h. 4 h, 24 h, 48 h and 96 h. Slit-widthsexcJem • 5/5 n m, t., • 120 µs and 
tg• 5 ms. 3.3. Luminescence properties of Ca doped dt EuP04 nH20 
nanoparticles 
3.3.1. Luminescence in solid state 
lt is well known that some lanthanides, espeàally europium 
(Ill) and terbium (Ill), form highly fluorescent chelates with many 
different organic ligands [56]. The sensitized fluorescence results 
from the ligand absorbing light, the energy of which is then trans 
ferred to the chelated metal ion ln fact, Eu(III) emits the energy as 
narrow banded, line type fluorescence with a long Stokes shift 
(over 250 nm) and an exceptionally long fluorescence decay time 
(up to 1 ms) [56]. Because of the long fluorescence decay time 
(over 10 times longer than the average background fluorescence) 
of Eu(III), a delay time (t,i) and a gate time (tg) can be used during 
the measuring, remarkably reducing the background fluorescence. The luminescence properties of solid Ca doped cit EuPO4 nH2O 
samples are practically the same as those depicted in Fig. 6 which 
correspond to x = 0.03 M Ca2\ neither the maturation time nor 
the ea2+ doping concentrations affect the excitation and emission 
wavelengths. 
The observed exàtation wavelengths for the powder were 319, 
362, 379, 394 and 465 nm which correspond to the Eu3• ion
7Fo -. 5H6, 7Fo -. 5D4, 7Fo -. 5l?, 7Fo -. 54, and 7Fo -. 5D2 transi
tions, and the emission wavelengths were 577, 590, 614, 650 and 
699 nm, which correspond to the Eu3• ion 5D0 -. 7F0, 5D0 -. 7Fi , 
5D0-. 7F2, 5DO-. 7F3 and 5D0-. 7F4 transitions, respectively [57].
This was expected because the electronic transitions of f orbitais 
are not affected by crystal's field. 
The emission wavelength corresponding to the hypersensitive 
transition (5D0-. 7F2, 614 nm) produces the highest relative lumi
nescence intensity. This is in agreement with the literature because 
this emission dominates the spectrum for nanosized particles [28]. 
Therefore, the optimum excitation and emission wavelengths of 
solid Ca doped àt EuPO4 nH2O were 394 nm and 614 nm, 
res pectively. 
Figure S4 (see SI) shows the effects of Eu (wt%), adsorbed water 
(wt%) and adsorbed citrate (wt%) from Table 1 on the relative lumi 
nescence intensity (R.LI). We deduce that the R.LI. determined in 
solid state is not affected by only one of these parameters individ 
ually. We can see, for instance, that the variation of R.L.I. with 
adsorbed water is abnormal, because water is a well known 
quencher of the luminescence. ln the same way, we cannot est ab 
lish a linear relationship between R.LI. and adsorbed citrate. Most 
likely several phenomena must overlap and compete (quenching, 
auto bleaching, energy transfer, effect of chemical structure and 
so on) that make complex the interpretation of the luminescent 
behavior in solid state. Anyway, as the main objective of these 
materials is to be employed for imaging applications, therefore dis 
persed in aqueous media, a deeper discussion of these aspects 
affecting the luminescence in solid state are out of the scope of this 
piece of work. 
An important parameter in luminescent complexes is the lumi 
nescence lifetime (,). The decrease of the R.L.I. versus time for pure 
cit EuPO4 nH2O (x = 0 M Ca) and for samples prepared with doping 
concentrations x = 0.01, 0.03, 0.05 and 0.06 M at 96 h is shown in 
Fig. SS of SI. For each case, the decay profile was analyzed as a sin 
gle exponential component (R.L.I. A e ''' + C) obtaining r of 
904, 1029, 1119, 1294 and 1083 µs, respectively. lt is possible to 
deduce that the luminescence lifetime for all materials is almost 
the same, of the order of the millisecond. This order of magnitude 
is similar to that of colloidal apatite nanoparticles stabilized with a 
phospholipid moiety, AEP [58), and points out a long luminescence 
lifetime as compared to the auto fluorescence of biological matter 
(of the order of the nanosecond), thus allowing us to envision 
applications as biomedical probes. 
3.3.2. Luminescence in aqueous suspensio n 
The luminescence properties of Ca doped cit EuPO4 H2O sam 
pies suspended in water are depicted in Fig. 7, which shows the 700 
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Fig. 7. Excitation (dashed line) and emission (solid line) spectra of Ca-<loped cit­
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Fig. 8. Variation of R.LL of Ca-<loped cit-EuP04-nH:i() samples dispersed in aqueous solu
slit-widthsexcfem • 5/5 nm, t., • 120 µs and tg• 5 ms. uncorrected exàtation and emission spectra. The maximum exci 
tation wavelength observed was 230 nm. This transition corre 
sponds to an electron that is transferred from the oxygen 2p 
orbital to an empty 4f orbital of the Europium, which is ascribed 
as a charge transfer state band [59 61 ). 
The observed emission wavelengths were 590, 616, 647 and 
696 nm, which correspond to the Eu3• ion 5D0 -. 7ft, 5D0 -. 7F2, 
5Do-. 7F3 and 5D0-. 7F4 transitions, respectively [57). The emis
sion wavelength corresponding to the hypersensitive transition 
(
5D 0-. 7F2, 616 nm) produces the highest relative luminescence
intensity, which once again agrees with the nanosized character 
of the material [28). Therefore, the optimum excitation and emis 
sion wavelengths of the Ca doped cit EuPO4 nH2O materials dis 
persed in water were 230 nm and 616 nm, respectively. 
On the other hand, it is also possible to observe that an increase 
on the ea2• doping concentration (which is related with a decrease 
of Eu3• content in the material) decreases the luminescence of the 
materials suspended in water. Analyzing the variation of the lumi 
nescence versus the Eu wt% according to Table 1, it is possible to 
establish a positive linear relationship (see Fig. Sa). Then, in this 
case, the luminescence variations are basically attributed to the 
amount of Eu in the materials and, therefore, all the effects that 
perturb the luminescence on solid state must be attenuated in 
the aqueous medium. 
lt is well known that the media affect the luminescence inten 
sities of luminophores [62). To obtain a deeper understanding, 
the effects of pH, ionic strength and temperature were evaluated. 
The influence of pH on the luminescence intensity was studied 
over the range 5.0 7.4 (Fig. Sb) and the effect of ionic strength was 
evaluated by suspending the particles in 0, 25, 50, 75 and 100 mM 
NaCI solutions (see SI, Fig. S6). lt is possible to deduce that neither 
the pH nor the ionic strength affect significantly the R.L.I. of the 
suspended materials, which is important for the final applications 
of these nanoparticles. 
The temperature may also theoretically affect the luminescence 
by quenching of the excited states; i.e. increasing T increases the 
molecular motion and collisions, and hence decreases the lumines 
cence emission by increasing encounters probabilities [63). Fig. S7 of 
SI shows the experimental results. To sum up, increasing from 25 to 
37 °C does not affect the luminescence emission of all the tested 
materials in aqueous suspension (0.05 and 0.01 M ea2•. maturation 
time of 96 h). The change in fluorescence intensity is norrnally 1% 
per degree Celsius [63) and the decreases for these materials were 
0.6 and 1.0% per degree Celsius, respectively. This is very important 
in view of medical and biomedical imaging ( ~ 37.4 °C).Ca 0.01 M 96 h -+-Ca 0.03 M 96 h --ca 0.05 M 96 h --ca 0.06 M 96 h 
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Fig. 9. Viability of GTL-16 cells (a) and of m17.ASC ceUs (b) incubated with Ca-<loped cit-EuP04-H:i() particles doped with dilferent concentration of Ca
2• for three days. 
Viability was assessed in MTT assays. Data represent means ± sd of three independent experiments performed in quadruplicate and statistical analyses were carried on using 
One-way ANOVA, with Bonferroni comparison test For statistical analysis ail data were compared to untreated samples ('p � 0.05, .. p � 0.01, ... p � 0.001 ). 3.4. Cytocompatibility of Ca doped dt EuP04 nHi) 
The cytocompatibility of cit EuPO4 nH2O samples doped with 
different concentrations of ea2• was tested in a MTT assay on the 
Gn 16 human carcinoma cells and on the ml 7.ASC murine mes 
enchymal stem cells, after incubation at concentrations ranging 
from 0.1 to 100 µg/ml. No toxicity was observed on GTL 16 cells 
at any nanoparticle concentration (Fig. 9a), since in all cases full 
cell viability was observed. In the case of mesenchymal stem cells, 
low levels of Eu3• were fully compatible with cell viability (Fig. 9b ).
However, if nanoparticles were doped with higher concentrations 
of Eu3• a certain level of toxicity was observed. In these cases,
the addition of doping ea2• in samples resulted in higher cell via 
bility in a dose response manner. In no case viability was lower 
than 70%, which is the eut offindicated by ISO 10993 5:2009 [64). 
The different behavior of the two cell lines is not unexpected, 
since it is largely reported from the literature that cell lines can dif 
fer in their sensitivity to external stimuli [65,66)  and indeed ml 7. 
ASC cells were already found to be Jess resistant than Gn 16 cells 
to the stress possibly induced by the presence of nanoparticles 
[39). On the other side, both cell types were sensitive to the toxic 
activity of doxorubicin, which reduced their viability to Jess than 
40%. This in vitro evaluation thus pointed out the good cytocompat 
ibility of the Ca doped àt EuPO4 nH2O nanoparticles. 
4. Con clusions 
This work was aimed to prepare luminescent EuPO4 nH2O 
nanophosphors doped with ea2• and coated with citrate since the 
presence of both components in the constitutive nanoparticles 
should be benefiàal regarding the cytocompatibility that is 
required for bioimaging applications. 
By applying the bioinspired crystallization route, consisting in 
thermal decomplexing of Ca2./Eu3• /citrate/phosphate/carbonate
solutions, we succeeded in preparing Ca doped citrate coated 
EuPO4 nH2O nanoparticles of the hexagonal rhabdophane phase. 
The general formula of this material, excluding citrate, is CaaEu1_ 
a(PO4)t.a(HPO4)a nH2O, with aranging from 0 to 0.58 and n ~1. 
Their average dimensions (length and width) are below ~40 nm 
and ~8 nm respectively, and their aspect ratio decreases from 5.0 
to 2.5 when the ea2• content increases, thus leading to more iso 
metric and irregular morphologies. Similar trend was found for 
the dimensions of the single crystal domains, whose coherent 
length and width are below ~13 and ~4 nm and the aspect ratio 
decreased from 3.6 to 1.1. In aqueous suspensions, these materials 
presented a low degree of aggregation below the median size (D501 
which become negligible below the percentile 10 (D10), and very low C potential values (mostly between 3 and 0.5 mV) in the 
pH rage from 11 to 4. 
Conceming the luminescence properties of these nanoparticles, 
neither the maturation time nor the concentration of doping agent 
affected significantly the excitation and emission wavelengths in 
solid state and aqueous suspensions. In solid state the observed 
excitation wavelengths were 319,362,379, 394 and 465 nm while 
the emission wavelengths were 577, 590, 614, 650 and 699 nm. In 
aqueous suspensions the maximum excitation wavelength 
observed was 230 nm and the emission wavelengths were 590, 
616, 647 and 696 nm. In aqueous suspensions it was found that 
relative luminescence intensity (R.LI.) is regulated by the ea2• level 
doping the structure, decreasing it by increasing the ea2• content 
(or decreasing Eu3• amount) of the nanoparticles. Neither the pH
(from 5 to 7.5) nor the ionic strength (from 0 to 100 mM NaCI), 
nor the temperature (from 25 to 37 °C) affected significantly the 
R.LI.
This class ofluminescent labeling agents is fully cytocompatible
when in contact with Gn 16 cells (a human gastric carcinoma cell 
line) and shows an improved cytocompatibility as the ea2• content 
increases, when in contact with the more sensitive ml 7 ASC cell 
line (a spontaneously immortalized mouse mesenchymal stem cell 
clone from subcutaneous adipose tissue). On the basis of these 
analysis and the data reported by other authors regarding in vivo 
biocompatibility of Eu doped calcium phosphates nanoparticles 
[67,68), it is expected that also these Ca2 doped EuPO4 nH2O 
nanoparticles would be biocompatible in vivo. They can thus 
appear as promising new tailorable tools in view of biomedical 
applications as luminescent nanoprobes. As an example, they could 
also be the starting blocks to develop multifunctional nanoparti 
des for efficient drug delivery, once coupled with therapeutic 
and targeting molecules [34). 
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